Practical tools to identify short children born small-for-gestational-age eligible for rhGH treatment according to Italian regulation

Recombinant human growth hormone (rhGH) is an approved and effective treatment for short children born small for gestational age (SGA). Prevalence of children eligible for treatment as SGA is reported to be 1:1800. The latest data from the National Registry of Growth Hormone therapy (RNAOC) showed t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ital J Pediatr
Egile Nagusiak: Tornese, Gianluca, Pricci, Flavia, Pellegrin, Maria Chiara, Villa, Marika, Rotondi, Daniela, Agazio, Elvira, Barbi, Egidio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Commentary
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6805524/
https://ncbi.nlm.nih.gov/pubmed/31639023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-019-0715-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak